+987.9%
MRNA vs AFRM
+8.5%
+979.4%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | AFRM | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +5.0% | +8.1% | +10.0% |
| 7D | +20.6% | +3.1% | +17.5% | +18.6% |
| 30D | +27.1% | +1.1% | +26.0% | +26.2% |
| 3M | +353.4% | -3.2% | +356.6% | +360.3% |
| 6M | +446.3% | +12.7% | +433.6% | +429.2% |
| YTD | +776.2% | +1.6% | +774.6% | +772.3% |
| 1Y | +987.9% | +5.9% | +982.1% | +978.4% |
| All | +987.9% | +8.5% | +979.4% | +978.4% |
Cumulative growth
Daily Returns
Daily percentage return beside AFRM.
Daily Out/Under-Performance
Portfolio return minus AFRM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × AFRM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded AFRM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling